{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["hyaluronic acid", "inflamed tissue targeting", "macrophage targeting", "nanoparticle", "ulcerative colitis therapy"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36297553", "DateRevised": {"Year": "2022", "Month": "10", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "05"}], "Language": ["eng"], "ELocationID": ["2118", "10.3390/pharmaceutics14102118"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "14", "Issue": "10", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "05"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages.", "Abstract": {"AbstractText": ["Although various local anti-inflammatory therapies for ulcerative colitis have been developed, rapid drug elimination from inflamed colitis tissue and off-target side effects reduce their therapeutic efficacy. In this study, we synthesized curcumin (Cur)-loaded hyaluronic acid (HA)-conjugated nanoparticles (Cur-HA-PLGA-NPs) that target inflamed colitis tissue via HA-CD44 interaction with resident colonic epithelial cells and subsequently target activated macrophages for ulcerative colitis therapy. The synthesized spherical Cur-HA-PLGA-NPs showed physicochemical properties similar to those of non-HA-conjugated Cur-PLGA-NPs. HA-PLGA-NPs exhibited selective accumulation in inflamed colitis tissue with minimal accumulation in healthy colon tissue. HA functionalization enhanced targeted drug delivery to intestinal macrophages, significantly increasing HA-PLGA-NP cellular uptake. Importantly, the rectal administration of Cur-HA-PLGA-NPs exhibited better therapeutic efficacy than Cur-PLGA-NPs in animal studies. Histological examination revealed that Cur-HA-PLGA-NPs reduced inflammation with less inflammatory cell infiltration and accelerated recovery with re-epithelialization signs. Our results suggest that Cur-HA-PLGA-NPs are a promising delivery platform for treating ulcerative colitis."]}, "AuthorList": [{"Identifier": ["0000-0003-0110-412X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Hlaing", "ForeName": "Shwe Phyu", "Initials": "SP"}, {"Identifier": ["0000-0002-9895-9388"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Cao", "ForeName": "Jiafu", "Initials": "J"}, {"Identifier": ["0000-0003-2831-3191"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Lee", "ForeName": "Juho", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Kim", "ForeName": "Jihyun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Saparbayeva", "ForeName": "Aruzhan", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Kwak", "ForeName": "Dongmin", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Kim", "ForeName": "Hyunwoo", "Initials": "H"}, {"Identifier": ["0000-0002-9728-3603"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Hwang", "ForeName": "Seonghwan", "Initials": "S"}, {"Identifier": ["0000-0003-1414-6169"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Yun", "ForeName": "Hwayoung", "Initials": "H"}, {"Identifier": ["0000-0003-1119-7112"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Moon", "ForeName": "Hyung Ryong", "Initials": "HR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Jung", "ForeName": "Yunjin", "Initials": "Y"}, {"Identifier": ["0000-0001-5216-5518"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea."}], "LastName": "Yoo", "ForeName": "Jin-Wook", "Initials": "JW"}], "GrantList": [{"GrantID": "NRF-2022R1A2C2004340", "Agency": "National Research Foundation of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kathleen A., Head N.D., Julie S., Jurenka M. Inflammatory bowel disease part i: Ulcerative colitis\u2013pathophysiology and conventional and alternative treatment options. Altern. Med. Rev. 2003;8:247\u2013283.", "ArticleIdList": ["12946238"]}, {"Citation": "Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., Benchimol E.I., Panaccione R., Ghosh S., Barkema H.W., et al. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review. Gastroenterology. 2012;142:46\u201354.:46\u201354.e42. doi: 10.1053/j.gastro.2011.10.001.", "ArticleIdList": ["10.1053/j.gastro.2011.10.001", "22001864"]}, {"Citation": "Sandborn W.J., Targan S.R. Biologic therapy of inflammatory bowel disease. Gastroenterology. 2002;122:1592\u20131608. doi: 10.1053/gast.2002.33426.", "ArticleIdList": ["10.1053/gast.2002.33426", "12016425"]}, {"Citation": "Kornbluth A., Sachar D.B. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee. Am. J. Gastroenterol. 2010;105:501\u2013523. doi: 10.1038/ajg.2009.727.", "ArticleIdList": ["10.1038/ajg.2009.727", "20068560"]}, {"Citation": "Feagan B.G., Chande N., Macdonald J.K. Are There Any Differences in the Efficacy and Safety of Different Formulations of Oral 5-ASA Used for Induction and Maintenance of Remission in Ulcerative Colitis? Evidence from Cochrane Reviews. Inflamm. Bowel Dis. 2013;19:2031\u20132040. doi: 10.1097/MIB.0b013e3182920108.", "ArticleIdList": ["10.1097/MIB.0b013e3182920108", "23811638"]}, {"Citation": "Kato S., Ishibashi A., Kani K., Yakabi K. Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository. Digestion. 2018;97:59\u201363. doi: 10.1159/000484224.", "ArticleIdList": ["10.1159/000484224", "29393142"]}, {"Citation": "Meijer B., Mulder C.J.J., Bouma G., Ponsioen C.Y., Van Der Woude C.J., Van Der Meulen A.E., Wintjens D.S.J., Dijkstra G., Hoentjen F., Oldenburg B., et al. Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness. Inflamm. Bowel Dis. 2018;24:1558\u20131565. doi: 10.1093/ibd/izy047.", "ArticleIdList": ["10.1093/ibd/izy047", "29668998"]}, {"Citation": "Lamprecht A., Sch\u00e4fer U., Lehr C.-M.M. Size-Dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 2001;18:788\u2013793. doi: 10.1023/A:1011032328064.", "ArticleIdList": ["10.1023/A:1011032328064", "11474782"]}, {"Citation": "Oshi M.A., Lee J., Naeem M., Hasan N., Kim J., Kim H.J., Lee E.H., Jung Y., Yoo J.-W. Curcumin Nanocrystal/pH-Responsive Polyelectrolyte Multilayer Core\u2013Shell Nanoparticles for Inflammation-Targeted Alleviation of Ulcerative Colitis. Biomacromolecules. 2020;21:3571\u20133581. doi: 10.1021/acs.biomac.0c00589.", "ArticleIdList": ["10.1021/acs.biomac.0c00589", "32701266"]}, {"Citation": "Oshi M.A., Naeem M., Bae J., Kim J., Lee J., Hasan N., Kim W., Im E., Jung Y., Yoo J.-W. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease. Carbohydr. Polym. 2018;198:434\u2013442. doi: 10.1016/j.carbpol.2018.06.107.", "ArticleIdList": ["10.1016/j.carbpol.2018.06.107", "30093020"]}, {"Citation": "Johansson M.E.V. Mucus Layers in Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2014;20:2124\u20132131. doi: 10.1097/MIB.0000000000000117.", "ArticleIdList": ["10.1097/MIB.0000000000000117", "25025717"]}, {"Citation": "Zhou X., Liu Y., Huang Y., Ma Y., Lv J., Xiao B. Mucus-penetrating polymeric nanoparticles for oral delivery of curcumin to inflamed colon tissue. J. Drug Deliv. Sci. Technol. 2019;52:157\u2013164. doi: 10.1016/j.jddst.2019.04.030.", "ArticleIdList": ["10.1016/j.jddst.2019.04.030"]}, {"Citation": "Bakhtiar A., Liew Q.X., Ng K.Y., Chowdhury E.H. Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells. J. Pharm. Investig. 2022;52:243\u2013257. doi: 10.1007/s40005-022-00559-x.", "ArticleIdList": ["10.1007/s40005-022-00559-x"]}, {"Citation": "He W., Kapate N., Shields C.W., Mitragotri S. Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases. Adv. Drug Deliv. Rev. 2020;165\u2013166:15\u201340. doi: 10.1016/j.addr.2019.12.001.", "ArticleIdList": ["10.1016/j.addr.2019.12.001", "31816357"]}, {"Citation": "Farkas S., Hornung M., Sattler C., Anthuber M., Gunthert U., Herfarth H., Schlitt H.J., Geissler E.K., Wittig B.M. Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin. Exp. Immunol. 2005;142:260\u2013267. doi: 10.1111/j.1365-2249.2005.02911.x.", "ArticleIdList": ["10.1111/j.1365-2249.2005.02911.x", "PMC1809521", "16232212"]}, {"Citation": "Hankard F., Cezard J.P., Aigrain Y., Navarro J., Peuchmaur M. CD44 variant expression in inflammatory colonic mucosa is not disease specific but associated with increased crypt cell proliferation. Histopathology. 1998;32:317\u2013321. doi: 10.1046/j.1365-2559.1998.00404.x.", "ArticleIdList": ["10.1046/j.1365-2559.1998.00404.x", "9602327"]}, {"Citation": "Dreaden E.C., Morton S.W., Shopsowitz K.E., Choi J.-H., Deng Z.J., Cho N.-J., Hammond P.T. Bimodal Tumor-Targeting from Microenvironment Responsive Hyaluronan Layer-by-Layer (LbL) Nanoparticles. ACS Nano. 2014;8:8374\u20138382. doi: 10.1021/nn502861t.", "ArticleIdList": ["10.1021/nn502861t", "PMC4148172", "25100313"]}, {"Citation": "Rosenberg W., Jackson D., Trowell J., Bell J., Prince C., Chapman R., Jewel D., Kaklamanis L., Fox S., Simmons D. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn\u2019s disease. Lancet. 1995;345:1205\u20131209. doi: 10.1016/S0140-6736(95)91991-0.", "ArticleIdList": ["10.1016/S0140-6736(95)91991-0", "7537840"]}, {"Citation": "Mahida Y.R. The Key Role of Macrophages in the Immunopathogenesis of Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2000;6:21\u201333. doi: 10.1097/00054725-200002000-00004.", "ArticleIdList": ["10.1097/00054725-200002000-00004", "10701146"]}, {"Citation": "Cai X., Wang X., He M., Wang Y., Lan M., Zhao Y., Gao F. Colon-targeted delivery of tacrolimus using pH-responsive polymeric nanoparticles for murine colitis therapy. Int. J. Pharm. 2021;606:120836. doi: 10.1016/j.ijpharm.2021.120836.", "ArticleIdList": ["10.1016/j.ijpharm.2021.120836", "34217824"]}, {"Citation": "Zhang M., Xu C., Liu D., Han M.K., Wang L., Merlin D. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis. J. Crohn\u2019s Colitis. 2018;12:217\u2013229. doi: 10.1093/ecco-jcc/jjx115.", "ArticleIdList": ["10.1093/ecco-jcc/jjx115", "PMC5881712", "28961808"]}, {"Citation": "Poh S., Chelvam V., Ayala-L\u00f3pez W., Putt K.S., Low P.S. Selective liposome targeting of folate receptor positive immune cells in inflammatory diseases. Nanomed. Nanotechnol. Biol. Med. 2018;14:1033\u20131043. doi: 10.1016/j.nano.2018.01.009.", "ArticleIdList": ["10.1016/j.nano.2018.01.009", "29410110"]}, {"Citation": "Deng F., He S., Cui S., Shi Y., Tan Y., Li Z., Huang C., Liu D., Zhi F., Peng L. A Molecular Targeted Immunotherapeutic Strategy for Ulcerative Colitis via Dual-targeting Nanoparticles Delivering miR-146b to Intestinal Macrophages. J. Crohn\u2019s Colitis. 2019;13:482\u2013494. doi: 10.1093/ecco-jcc/jjy181.", "ArticleIdList": ["10.1093/ecco-jcc/jjy181", "30445446"]}, {"Citation": "Huang Z., Gan J., Jia L., Guo G., Wang C., Zang Y., Ding Z., Chen J., Zhang J., Dong L. An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease. Biomaterials. 2015;48:26\u201336. doi: 10.1016/j.biomaterials.2015.01.013.", "ArticleIdList": ["10.1016/j.biomaterials.2015.01.013", "25701029"]}, {"Citation": "Poudel S., Napit P., Briski K., Mattheolabakis G. Oral Delivery of Nucleic Acids with Passive and Active Targeting to the Intestinal Tissue Using Polymer-Based Nanocarriers. Pharmaceutics. 2021;13:1075. doi: 10.3390/pharmaceutics13071075.", "ArticleIdList": ["10.3390/pharmaceutics13071075", "PMC8309160", "34371766"]}, {"Citation": "Liu P., Gao C., Chen H., Vong C.T., Wu X., Tang X., Wang S., Wang Y. Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies. Acta Pharm. Sin. B. 2021;11:2798\u20132818. doi: 10.1016/j.apsb.2020.11.003.", "ArticleIdList": ["10.1016/j.apsb.2020.11.003", "PMC8463263", "34589398"]}, {"Citation": "Nguyen H.T.T., Merlin D. Homeostatic and innate immune responses: Role of the transmembrane glycoprotein CD98. Experientia. 2012;69:3015\u20133026. doi: 10.1007/s00018-012-0963-z.", "ArticleIdList": ["10.1007/s00018-012-0963-z", "PMC4402973", "22460579"]}, {"Citation": "Kucharzik T., Lugering A., Yan Y., Driss A., Charrier L., Sitaraman S., Merlin D. Activation of epithelial CD98 glycoprotein perpetuates colonic inflammation. Lab. Investig. 2005;85:932\u2013941. doi: 10.1038/labinvest.3700289.", "ArticleIdList": ["10.1038/labinvest.3700289", "15880135"]}, {"Citation": "Cao J., Naeem M., Noh J.-K., Lee E.H., Yoo J.-W. Dexamethasone phosphate-loaded folate-conjugated polymeric nanoparticles for selective delivery to activated macrophages and suppression of inflammatory responses. Macromol. Res. 2015;23:485\u2013492. doi: 10.1007/s13233-015-3065-6.", "ArticleIdList": ["10.1007/s13233-015-3065-6"]}, {"Citation": "Gou S., Huang Y., Wan Y., Ma Y., Zhou X., Tong X., Huang J., Kang Y., Pan G., Dai F., et al. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis. Biomaterials. 2019;212:39\u201354. doi: 10.1016/j.biomaterials.2019.05.012.", "ArticleIdList": ["10.1016/j.biomaterials.2019.05.012", "31103945"]}, {"Citation": "Zhu S., Niu M., O\u2019Mary H., Cui Z. Targeting of Tumor-Associated Macrophages Made Possible by PEG-Sheddable, Mannose-Modified Nanoparticles. Mol. Pharm. 2013;10:3525\u20133530. doi: 10.1021/mp400216r.", "ArticleIdList": ["10.1021/mp400216r", "PMC3946577", "23901887"]}, {"Citation": "Dignass A., Lindsay J.O., Sturm A., Windsor A., Colombel J.-F., Allez M., D\u2019Haens G., D\u2019Hoore A., Mantzaris G., Novacek G., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management. J. Crohn\u2019s Colitis. 2012;6:991\u20131030. doi: 10.1016/j.crohns.2012.09.002.", "ArticleIdList": ["10.1016/j.crohns.2012.09.002", "23040451"]}, {"Citation": "Liao Y.-H., Jones S.A., Forbes B., Martin G.P., Brown M.B. Hyaluronan: Pharmaceutical Characterization and Drug Delivery. Drug Deliv. 2005;12:327\u2013342. doi: 10.1080/10717540590952555.", "ArticleIdList": ["10.1080/10717540590952555", "16253949"]}, {"Citation": "Vasvani S., Kulkarni P., Rawtani D. Hyaluronic acid: A review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies. Int. J. Biol. Macromol. 2020;151:1012\u20131029. doi: 10.1016/j.ijbiomac.2019.11.066.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.11.066", "31715233"]}, {"Citation": "Wang H., Zhang Y., Liu Y., Ren Y., Wang J., Niu B., Li W. Preparation of curcumin loaded hyaluronic acid-poly (lactic-co-glycolic acid) micelles with pH response and tumor targeting. Eur. Polym. J. 2022;177:111450. doi: 10.1016/j.eurpolymj.2022.111450.", "ArticleIdList": ["10.1016/j.eurpolymj.2022.111450"]}, {"Citation": "Lu H.-D., Zhao H.-Q., Wang K., Lv L.-L. Novel hyaluronic acid\u2013chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis. Int. J. Pharm. 2011;420:358\u2013365. doi: 10.1016/j.ijpharm.2011.08.046.", "ArticleIdList": ["10.1016/j.ijpharm.2011.08.046", "21911044"]}, {"Citation": "Jana P., Shyam M., Singh S., Jayaprakash V., Dev A. Biodegradable polymers in drug delivery and oral vaccination. Eur. Polym. J. 2020;142:110155. doi: 10.1016/j.eurpolymj.2020.110155.", "ArticleIdList": ["10.1016/j.eurpolymj.2020.110155"]}, {"Citation": "Anwar M., Muhammad F., Akhtar B. Biodegradable nanoparticles as drug delivery devices. J. Drug Deliv. Sci. Technol. 2021;64:102638. doi: 10.1016/j.jddst.2021.102638.", "ArticleIdList": ["10.1016/j.jddst.2021.102638"]}, {"Citation": "Jacob A., Wu R., Zhou M., Wang P. Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-\u03b3Activation. PPAR Res. 2007;2007:89369. doi: 10.1155/2007/89369.", "ArticleIdList": ["10.1155/2007/89369", "PMC2234255", "18274631"]}, {"Citation": "Lee J., Hlaing S.P., Hasan N., Kwak D., Kim H., Cao J., Yoon I.-S., Yun H., Jung Y., Yoo J.-W. Tumor-Penetrable Nitric Oxide-Releasing Nanoparticles Potentiate Local Antimelanoma Therapy. ACS Appl. Mater. Interfaces. 2021;13:30383\u201330396. doi: 10.1021/acsami.1c07407.", "ArticleIdList": ["10.1021/acsami.1c07407", "34162207"]}, {"Citation": "Hlaing S.P., Kim J., Lee J., Hasan N., Cao J., Naeem M., Lee E.H., Shin J.H., Jung Y., Lee B.-L., et al. S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds. Eur. J. Pharm. Biopharm. 2018;132:94\u2013102. doi: 10.1016/j.ejpb.2018.09.009.", "ArticleIdList": ["10.1016/j.ejpb.2018.09.009", "30223029"]}, {"Citation": "Chassaing B., Aitken J.D., Malleshappa M., Vijay-Kumar M. Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Curr. Protoc. Immunol. 2014;104:15.25.1\u201315.25.14. doi: 10.1002/0471142735.im1525s104.", "ArticleIdList": ["10.1002/0471142735.im1525s104", "PMC3980572", "24510619"]}, {"Citation": "Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis.  [(accessed on 1 August 2022)];Lab. Investig. A J. Tech. Methods Pathol. 1993 69:238\u2013249. Available online:  https://europepmc.org/article/med/99#impact.", "ArticleIdList": ["8350599"]}, {"Citation": "Makhlof A., Tozuka Y., Takeuchi H. pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. Eur. J. Pharm. Biopharm. 2009;72:1\u20138. doi: 10.1016/j.ejpb.2008.12.013.", "ArticleIdList": ["10.1016/j.ejpb.2008.12.013", "19348015"]}, {"Citation": "Cummins E.P., Seeballuck F., Keely S.J., Mangan N.E., Callanan J.J., Fallon P.G., Taylor C.T. The Hydroxylase Inhibitor Dimethyloxalylglycine Is Protective in a Murine Model of Colitis. Gastroenterology. 2008;134:156\u2013165.e1. doi: 10.1053/j.gastro.2007.10.012.", "ArticleIdList": ["10.1053/j.gastro.2007.10.012", "18166353"]}, {"Citation": "Weigmann B., Lehr H.A., Yancopoulos G., Valenzuela D., Murphy A., Stevens S., Schmidt J., Galle P.R., Rose-John S., Neurath M.F. The transcription factor NFATc2 controls IL-6\u2013dependent T cell activation in experimental colitis. J. Exp. Med. 2008;205:2099\u20132110. doi: 10.1084/jem.20072484.", "ArticleIdList": ["10.1084/jem.20072484", "PMC2526204", "18710929"]}, {"Citation": "Young N.A., Bruss M.S., Gardner M., Willis W.L., Mo X., Valiente G.R., Cao Y., Liu Z., Jarjour W.N., Wu L.-C. Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NF\u03baB Signaling and Macrophage Migration. PLoS ONE. 2014;9:e111559. doi: 10.1371/journal.pone.0111559.", "ArticleIdList": ["10.1371/journal.pone.0111559", "PMC4219720", "25369140"]}, {"Citation": "Ukil A., Maity S., Karmakar S., Datta N., Vedasiromoni J.R., Das P.K. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. J. Cereb. Blood Flow Metab. 2003;139:209\u2013218. doi: 10.1038/sj.bjp.0705241.", "ArticleIdList": ["10.1038/sj.bjp.0705241", "PMC1573841", "12770926"]}, {"Citation": "Lertpairod J., Tiyaboonchai W. pH-sensitive beads containing curcumin loaded nanostructured lipid carriers for a colon targeted oral delivery system. J. Pharm. Investig. 2022;52:387\u2013396. doi: 10.1007/s40005-022-00572-0.", "ArticleIdList": ["10.1007/s40005-022-00572-0"]}, {"Citation": "Price L.C., Buescher R. Kinetics of Alkaline Degradation of the Food Pigments Curcumin and Curcuminoids. J. Food Sci. 1997;62:267\u2013269. doi: 10.1111/j.1365-2621.1997.tb03982.x.", "ArticleIdList": ["10.1111/j.1365-2621.1997.tb03982.x"]}, {"Citation": "T\u00f8nnesen H.H., M\u00e1sson M., Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int. J. Pharm. 2002;244:127\u2013135. doi: 10.1016/S0378-5173(02)00323-X.", "ArticleIdList": ["10.1016/S0378-5173(02)00323-X", "12204572"]}, {"Citation": "Van Der Waaij L.A., Harmsen H.J.M., Madjipour M., Kroese F.G.M., Zwiers M., Van Dullemen H.M., De Boer N.K., Welling G.W., Jansen P.L.M. Bacterial Population Analysis of Human Colon and Terminal Ileum Biopsies with 16S rRNA-based Fluorescent Probes: Commensal Bacteria Live in Suspension and Have No Direct Contact with Epithelial Cells. Inflamm. Bowel Dis. 2005;11:865\u2013871. doi: 10.1097/01.mib.0000179212.80778.d3.", "ArticleIdList": ["10.1097/01.mib.0000179212.80778.d3", "16189415"]}, {"Citation": "Li X., Guo S., Zhu C., Zhu Q., Gan Y., Rantanen J., Rahbek U.L., Hovgaard L., Yang M. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Biomaterials. 2013;34:9678\u20139687. doi: 10.1016/j.biomaterials.2013.08.048.", "ArticleIdList": ["10.1016/j.biomaterials.2013.08.048", "24016855"]}, {"Citation": "Wu L., Shan W., Zhang Z., Huang Y. Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties. Adv. Drug Deliv. Rev. 2018;124:150\u2013163. doi: 10.1016/j.addr.2017.10.001.", "ArticleIdList": ["10.1016/j.addr.2017.10.001", "28989056"]}, {"Citation": "Johansson M.E.V. Fast Renewal of the Distal Colonic Mucus Layers by the Surface Goblet Cells as Measured by In Vivo Labeling of Mucin Glycoproteins. PLoS ONE. 2012;7:e41009. doi: 10.1371/journal.pone.0041009.", "ArticleIdList": ["10.1371/journal.pone.0041009", "PMC3398881", "22815896"]}, {"Citation": "Xiao B., Xu Z., Viennois E., Zhang Y., Zhang Z., Zhang M., Han M.K., Kang Y., Merlin D. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Mol. Ther. 2017;25:1628\u20131640. doi: 10.1016/j.ymthe.2016.11.020.", "ArticleIdList": ["10.1016/j.ymthe.2016.11.020", "PMC5498804", "28143741"]}, {"Citation": "Tran T.-H., Rastogi R., Shelke J., Amiji M.M. Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid Nanoparticles. Sci. Rep. 2015;5:16632. doi: 10.1038/srep16632.", "ArticleIdList": ["10.1038/srep16632", "PMC4649614", "26577684"]}, {"Citation": "Kim J., Shajib S., Manocha M.M., Khan W.I. Investigating Intestinal Inflammation in DSS-induced Model of IBD. J. Vis. Exp. 2012;60:3678. doi: 10.3791/3678.", "ArticleIdList": ["10.3791/3678", "PMC3369627", "22331082"]}, {"Citation": "Viennois E., Xiao B., Ayyadurai S., Wang L., Wang P.G., Zhang Q., Chen Y., Merlin D. Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer. Lab. Investig. 2014;94:950\u2013965. doi: 10.1038/labinvest.2014.89.", "ArticleIdList": ["10.1038/labinvest.2014.89", "25068660"]}, {"Citation": "Poh S., Lin J.B., Panitch A. Release of Anti-inflammatory Peptides from Thermosensitive Nanoparticles with Degradable Cross-Links Suppresses Pro-inflammatory Cytokine Production. Biomacromolecules. 2015;16:1191\u20131200. doi: 10.1021/bm501849p.", "ArticleIdList": ["10.1021/bm501849p", "PMC4839979", "25728363"]}, {"Citation": "Uings I., Puxeddu I., Temkin V., Smith S.J., Fattah D., Ray K.P., Levi-Schaffer F. Effects of dexamethasone on TNF-alpha-induced release of cytokines from purified human blood eosinophils. Clin. Mol. Allergy. 2005;3:5. doi: 10.1186/1476-7961-3-5.", "ArticleIdList": ["10.1186/1476-7961-3-5", "PMC1131914", "15857511"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "30"}, {"Year": "2022", "Month": "10", "Day": "1"}, {"Year": "2022", "Month": "10", "Day": "2"}, {"Year": "2022", "Month": "10", "Day": "27", "Hour": "1", "Minute": "51"}, {"Year": "2022", "Month": "10", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["36297553", "PMC9612393", "10.3390/pharmaceutics14102118", "pharmaceutics14102118"]}}], "PubmedBookArticle": []}